<VariationArchive RecordType="classified" VariationID="11124" VariationName="NM_000377.3(WAS):c.1097del (p.Gly366fs)" VariationType="Deletion" Accession="VCV000011124" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2022-04-25" DateCreated="2018-12-15" MostRecentSubmission="2018-12-15">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="26163" VariationID="11124">
      <GeneList>
        <Gene Symbol="WAS" FullName="WASP actin nucleation promoting factor" GeneID="7454" HGNC_ID="HGNC:12731" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>Xp11.23</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="48676636" stop="48691427" display_start="48676636" display_stop="48691427" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="48542185" stop="48549817" display_start="48542185" display_stop="48549817" Strand="+" />
          </Location>
          <OMIM>300392</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000377.3(WAS):c.1097del (p.Gly366fs)</Name>
      <CanonicalSPDI>NC_000023.11:48688820:GGGGG:GGGG</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>Xp11.23</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="48688821" stop="48688821" display_start="48688821" display_stop="48688821" variantLength="1" positionVCF="48688820" referenceAlleleVCF="AG" alternateAlleleVCF="A" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="48547210" stop="48547210" display_start="48547210" display_stop="48547210" variantLength="1" positionVCF="48547209" referenceAlleleVCF="AG" alternateAlleleVCF="A" />
      </Location>
      <ProteinChange>G366fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.10" sequenceAccession="NC_000023" sequenceVersion="10" change="g.48547214del" Assembly="GRCh37">
            <Expression>NC_000023.10:g.48547214del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.11" sequenceAccession="NC_000023" sequenceVersion="11" change="g.48688825del" Assembly="GRCh38">
            <Expression>NC_000023.11:g.48688825del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_007877.1" sequenceAccession="NG_007877" sequenceVersion="1" change="g.10029del">
            <Expression>NG_007877.1:g.10029del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000377.3" sequenceAccession="NM_000377" sequenceVersion="3" change="c.1097del" MANESelect="true">
            <Expression>NM_000377.3:c.1097del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000368.1" sequenceAccession="NP_000368" sequenceVersion="1" change="p.Gly366fs">
            <Expression>NP_000368.1:p.Gly366fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_125" sequenceAccession="LRG_125">
            <Expression>LRG_125:g.10029del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_125t1" sequenceAccession="LRG_125t1">
            <Expression>LRG_125t1:c.1097del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_125p1" sequenceAccession="LRG_125p1" change="p.Gly366fs">
            <Expression>LRG_125p1:p.Gly366fs</Expression>
          </ProteinExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA341014" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="300392.0011" DB="OMIM" />
        <XRef Type="rs" ID="587776744" DB="dbSNP" />
      </XRefList>
      <Comment DataSource="NCBI curation" Type="public">NCBI staff reviewed the sequence information reported in PubMed 9657775 Fig. 1 to determine the location of this allele on the current reference sequence.</Comment>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000377.3(WAS):c.1097del (p.Gly366fs) AND Wiskott-Aldrich syndrome" Accession="RCV000011873" Version="8">
        <ClassifiedConditionList TraitSetID="3075">
          <ClassifiedCondition DB="MedGen" ID="C0043194">Wiskott-Aldrich syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="1998-07-15" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="1998-07-15" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2018-12-15" MostRecentSubmission="2018-12-15">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">8673127</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">9657775</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="3075" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="6264" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Eczema thrombocytopenia immunodeficiency syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Immunodeficiency 2</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">IMD 2</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Aldrich syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Wiskott-aldrich syndrome, somatic</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">WISKOTT-ALDRICH SYNDROME 1</ElementValue>
                <XRef Type="MIM" ID="301000" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Wiskott-Aldrich syndrome</ElementValue>
                <XRef ID="Wiskott+Aldrich+syndrome/7514" DB="Genetic Alliance" />
                <XRef ID="MONDO:0010518" DB="MONDO" />
                <XRef ID="36070007" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">WAS1</ElementValue>
                <XRef Type="MIM" ID="301000" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">IMD2</ElementValue>
                <XRef Type="MIM" ID="301000" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">WAS</ElementValue>
                <XRef Type="MIM" ID="301000" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">The WAS-related disorders, which include Wiskott-Aldrich syndrome, X-linked thrombocytopenia (XLT), and X-linked congenital neutropenia (XLN), are a spectrum of disorders of hematopoietic cells, with predominant defects of platelets and lymphocytes caused by pathogenic variants in WAS. WAS-related disorders usually present in infancy. Affected males have thrombocytopenia with intermittent mucosal bleeding, bloody diarrhea, and intermittent or chronic petechiae and purpura; eczema; and recurrent bacterial and viral infections, particularly of the ear. At least 40% of those who survive the early complications develop one or more autoimmune conditions including hemolytic anemia, immune thrombocytopenic purpura, immune-mediated neutropenia, rheumatoid arthritis, vasculitis, and immune-mediated damage to the kidneys and liver. Individuals with a WAS-related disorder, particularly those who have been exposed to Epstein-Barr virus (EBV), are at increased risk of developing lymphomas, which often occur in unusual, extranodal locations including the brain, lung, or gastrointestinal tract. Males with XLT have thrombocytopenia with small platelets; other complications of Wiskott-Aldrich syndrome, including eczema and immune dysfunction, are usually mild or absent. Males with XLN have congenital neutropenia, myeloid dysplasia, and lymphoid cell abnormalities.</Attribute>
                <XRef ID="NBK1178" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="7895" />
                <XRef ID="7895" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301357</ID>
                <ID Source="BookShelf">NBK1178</ID>
              </Citation>
              <XRef ID="906" DB="Orphanet" />
              <XRef ID="C0043194" DB="MedGen" />
              <XRef ID="MONDO:0010518" DB="MONDO" />
              <XRef Type="MIM" ID="301000" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="32106" SubmissionDate="2018-01-16" DateLastUpdated="2018-12-15" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="300392.0011_WISKOTT-ALDRICH SYNDROME" title="WAS, 1-BP DEL, 1127G_WISKOTT-ALDRICH SYNDROME" />
        <ClinVarAccession Accession="SCV000032106" DateUpdated="2018-12-15" DateCreated="2013-04-04" Type="SCV" Version="2" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="1998-07-15">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a patient with Wiskott-Aldrich syndrome (WAS; 301000), Ariga et al. (1998) observed 2 mutations in exon 10 of the WASP gene. One mutation was a 1-bp insertion (A) at nucleotide 1099 or 1100. The other was a 1-base deletion (G) from 5 consecutive Gs at nucleotides 1127 to 1131. On further study it was found that some clones contained only the insertion mutation and the patient's mother and sister, who were both carriers, had only the deletion mutation. It was suggested that the insertion mutation occurred somatically in a hematologic progenitor and was potentially capable of correcting the inherited defect. The proband died at the age of 4 years from intracranial hemorrhage; 2 older brothers who also had Wiskott-Aldrich syndrome died at the ages of 10 months and 47 months. It was uncertain whether the proband's disorder was milder as a result of the second mutation. Spontaneous in vivo reversion to normal of an inherited mutation was reported in a patient with adenosine deaminase deficiency (102700.0026) by Hirschhorn et al. (1996).</Attribute>
              <Citation>
                <ID Source="PubMed">9657775</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">8673127</ID>
              </Citation>
              <XRef DB="OMIM" ID="301000" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="WAS" />
          </GeneList>
          <Name>WAS, 1-BP DEL, 1127G</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP DEL, 1127G</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="300392.0011" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">WISKOTT-ALDRICH SYNDROME</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="32106" TraitType="Disease" MappingType="Name" MappingValue="WISKOTT-ALDRICH SYNDROME" MappingRef="Preferred">
        <MedGen CUI="C0043194" Name="Wiskott-Aldrich syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

